These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Smith SR; Blundell JE; Burns C; Ellero C; Schroeder BE; Kesty NC; Chen KS; Halseth AE; Lush CW; Weyer C Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E620-7. PubMed ID: 17505051 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Mack C; Wilson J; Athanacio J; Reynolds J; Laugero K; Guss S; Vu C; Roth J; Parkes D Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1855-63. PubMed ID: 17855496 [TBL] [Abstract][Full Text] [Related]
8. Amylin-mediated control of glycemia, energy balance, and cognition. Mietlicki-Baase EG Physiol Behav; 2016 Aug; 162():130-40. PubMed ID: 26922873 [TBL] [Abstract][Full Text] [Related]
9. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice. Leinung MC; Grasso P Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403 [TBL] [Abstract][Full Text] [Related]
10. Intermittent High-Fat Diet Intake Reduces Sensitivity to Intragastric Nutrient Infusion and Exogenous Amylin in Female Rats. Maske CB; Coiduras II; Ondriezek ZE; Terrill SJ; Williams DL Obesity (Silver Spring); 2020 May; 28(5):942-952. PubMed ID: 32237211 [TBL] [Abstract][Full Text] [Related]
11. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Ravussin E; Smith SR; Mitchell JA; Shringarpure R; Shan K; Maier H; Koda JE; Weyer C Obesity (Silver Spring); 2009 Sep; 17(9):1736-43. PubMed ID: 19521351 [TBL] [Abstract][Full Text] [Related]
18. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus. Singh-Franco D; Robles G; Gazze D Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279 [TBL] [Abstract][Full Text] [Related]
19. Amylin: a novel action in the brain to reduce body weight. Rushing PA; Hagan MM; Seeley RJ; Lutz TA; Woods SC Endocrinology; 2000 Feb; 141(2):850-3. PubMed ID: 10650969 [TBL] [Abstract][Full Text] [Related]
20. Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat. Coccurello R; Romano A; Giacovazzo G; Tempesta B; Fiore M; Giudetti AM; Marrocco I; Altieri F; Moles A; Gaetani S Eur J Nutr; 2018 Jun; 57(4):1485-1498. PubMed ID: 28314964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]